omniture
logo
Search

/DISREGARD RELEASE: IASO Bio/

IASO Bio
2026-08-14 13:30 4186

We are advised by IASO Bio that journalists and other readers should disregard the news release, IASO Biotechnology Announces Acquisition of Singapore-Based Cell Therapy Company MediSix Therapeutics, issued 13-Aug-2026 over PR Newswire, as the release contained erroneous information.

Source: IASO Bio
Media Room more

IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH

2025-12-08 09:57
2179

IASO Bio Announces BLA Approval of Fucaso (Equecabtagene Autoleucel) by the Hong Kong Department of Health for the Treatment of Relapsed or Refractory Multiple Myeloma

2025-11-27 13:44
2399

IASO Bio Partners with Korea's GC Cell to Bring CAR-T Therapy to Korea

2025-10-29 17:01
1966
Signing ceremony photo: From left, Sungyong Won, Co-CEO of GC Cell, and Jinhua Zhang, Founder, Chairman, and CEO of IASO Bio

Blood Publishes Promising Results of IASO Bio's Anti-GPRC5D CAR-T RD118 in Relapsed/Refractory Multiple Myeloma

2025-10-22 19:39
2339

Cell Publishes Breakthrough Research Results of IASO Bio's Anti-BCMA CAR-T Equecabtagene Autoleucel in Autoimmune Disease Multiple Sclerosis

2025-10-16 20:45
2703

2025 IMS | IASO Bio Highlights Three-Year Follow-Up Data of CAR-T Cell Therapy Fucaso for Multiple Myeloma Treatment

2025-09-19 09:39
3260
Prof. Lugui Qiu delivering an oral presentation at the 2025 IMS Annual Meeting in Toronto, Canada, on September 18
Related News

DIMERIX SECURES A$34 MILLION NON-DILUTIVE FACILITY TO FUND KEY CLINICAL MILESTONES

2026-09-04 19:00
1939

Acepodia Announces FDA Clearance of IND Application for ACE723, a Novel Dual-Payload Antibody-Drug Conjugate

2026-09-04 19:00
1767

DIMERIX SECURES A$34 MILLION NON-DILUTIVE FACILITY TO FUND KEY CLINICAL MILESTONES

2026-09-04 11:00
2177

AtomVie Global Radiopharma Celebrates the Grand Opening of its New State-of-the-Art Radiopharmaceutical Manufacturing Facility in Hamilton, Ontario

2026-09-05 00:29
3069
Ribbon cutting at the Grand Opening of AtomVie Global Radiopharma’s new purpose-built radiopharmaceutical manufacturing facility in Hamilton, Ontario.

TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations

2026-09-03 22:00
1967

Neurophet Appoints Leading U.S. Dementia Imaging Expert Dr. Ana M. Franceschi as Scientific Advisor

2026-09-03 21:00
2334
Neurophet Appoints Leading U.S. Dementia Imaging Expert Dr. Ana M. Franceschi as Scientific Advisor
collection